From Theory to Practice: Incorporating Polygenic Risk Scores in Breast Cancer Treatment

Please join us for this webinar where we will explore the landscape of polygenic risk scores (PRS), highlighting both commercially available and research-based products.

Describe the historical development and scientific rationale behind polygenic risk scores (PRS) and combined residual risk scores in genetic risk assessment. Evaluate current literature on the clinical utility and limitations of breast cancer PRS in various healthcare settings. Identify practical strategies for integrating polygenic risk scores into shared decision-making.